Michael Li

Michael Li practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Michael Li's NPI, 1508253303, was assigned on April 20, 2015. Michael Li graduated from Icahn School Of Medicine At Mount Sinai in 2015. Michael Li holds California license A171722.

Michael Li's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Michael Li's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Michael Li is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Michael Li to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Li practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Michael Li's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Michael Li is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Michael Li's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver and upper GI endoscopy among the conditions Michael Li treats.

CMS data shows 419 Medicare services from Michael Li across 9 procedure codes in 2024, for 198 Medicare patients. Medicare paid $32,928 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Michael Li in 2024. The largest group is 65 to 74, with 93 patients. 74% of them have high blood pressure, and 61% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Li's median patient age at 61, with 49% women.

In 2024, Michael Li wrote 341 Medicare Part D claims for 72 patients. 74% of them were for generic drugs. CMS names the drug for 248 of them, across 10 drugs with 11 or more claims each, at $202,369 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Michael Li for performance year 2024, reported as part of a group. Michael Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Li as offering telehealth. CMS counts 24 procedures of colonoscopy by Michael Li, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Michael Li, published from 2015 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Immune Checkpoint Inhibitors, Chemical and Drug Induced Liver Injury and Hepatitis. Michael Li has published most often in Hepatol Commun. Michael Li's most frequent co-authors are Jennifer C. Lai, MBA, MD, Stephen David Zucker, MD and Shilpa Grover, MD.

CMS Open Payments shows 6 general payments to Michael Li from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 45% of the total. Taiho Oncology, Inc. paid the most, $154.

Michael Li graduated from Icahn School Of Medicine At Mount Sinai in 2015. Michael Li is a member of American Association for the Study of Liver Diseases, ACG and AGA.

Michael Li is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.